ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,385.02
-0.47%
Dow Jones
39,806.77
0.00%
Gold vs US Dollar
2,429.00
0.10%
Brent Oil
82.305
-1.47%
Bitcoin
71,290.42
-0.22%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. ATAI Life Sciences NV (ATAI) Share Price

ATAI ATAI Life Sciences NV

1.798
0.068 (3.93%)
Pre Market
Last Updated: 13:29:44
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 ATAI Life Sciences NV NASDAQ:ATAI NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.068 3.93 1.798 1.71 1.81 0.00 0.00  6,741 12:29:44   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Intermediate Care Facilities 314k -40.22M -0.2423 -7.14 287.2M
 Type  Size  Price  Time  Units 
 20 100 1.798 12:29:44 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ATAI News
20/05/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
15/05/202412:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/05/202412:15EDGAR2Form 8-K - Current report
15/05/202411:59GLOBEatai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
24/04/202412:00GLOBEatai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
17/04/202412:00GLOBEatai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
28/03/202411:00GLOBEatai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
Period
Draw mode
Data Downloads for ATAI

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest ATAI Life Sciences NV Articles